← Leaderboards
Luigi Daniele Notarangelo
Beth Israel Deaconess Medical Center
$5,304,366
Attributed
$6,474,816
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–16$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$6,474,816 · 7
By mechanism
P01$3,032,604 · 2
R01$2,280,901 · 1
R21$929,926 · 2
R03$171,385 · 1
R13$60,000 · 1
Top collaborators
- Juan Carlos Zuniga-Pflucker4 shared
- Morton Cowan3 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Joyce D Fingeroth$3,766,291
Others in their field
Top investigators on “Mutation”
- Richard A Gibbs · Baylor College Of Medicine$276,143,183
- David Heimbrook · Leidos Biomedical Research, Inc.$175,834,894
- Randall J Bateman · Washington University$154,391,630
- Eric Martin McDade · Washington University$96,219,353
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,475,056
Research focus
MutationImmuneGenerationsInfectionT-LymphocyteAffectGenesDefectPhenotypeCellsImmunologic Deficiency SyndromesIn VitroIn VivoGene TherapyBaseT-Cell DevelopmentSkinScid MiceB-LymphocytesMediatingCell LineStem CellsMolecularSyndrome
Grant awards (21)
Characterization of a novel combined immunodeficiency with skeletal dysplasia$221,250
R21 · FY2016 · AI · contact PI
Modeling and correcting human SCID using patient-derived iPS cells$569,518
R01 · FY2015 · AI · contact PI
Characterization of a novel combined immunodeficiency with skeletal dysplasia$264,375
R21 · FY2015 · AI · contact PI
Modeling and correcting human SCID using patient-derived iPS cells$569,518
R01 · FY2014 · AI · contact PI
Modeling and correcting human SCID using patient-derived iPS cells$535,347
R01 · FY2013 · AI · contact PI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID$473,304
P01 · FY2013 · AI · contact PI
Primary Immune Deficiency Treatment Consortium Annual Scientific Meeting$20,000
R13 · FY2013 · AI
Modeling and correcting human SCID using patient-derived iPS cells$606,518
R01 · FY2012 · AI · contact PI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID$493,639
P01 · FY2012 · AI · contact PI
Role of WASP and N-WASP in B cell maturation, homing and function$199,704
P01 · FY2012 · HL · contact PI
Primary Immune Deficiency Treatment Consortium Annual Scientific Meeting$20,000
R13 · FY2012 · AI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID$479,312
P01 · FY2011 · AI · contact PI
In vitro differentiation of RAG1-mutated iPS cells and correction by meganuclease$234,084
R21 · FY2011 · AI · contact PI
Role of WASP and N-WASP in B cell maturation, homing and function$215,291
P01 · FY2011 · HL · contact PI
Reprogramming of fibroblasts to pluripotency- a new tool to study Primary Immunod$85,635
R03 · FY2011 · AI · contact PI
Primary Immune Deficiency Treatment Consortium Annual Scientific Meeting$20,000
R13 · FY2011 · AI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID$479,139
P01 · FY2010 · AI · contact PI
Role of WASP and N-WASP in B cell maturation, homing and function$214,946
P01 · FY2010 · HL · contact PI
In vitro differentiation of RAG1-mutated iPS cells and correction by meganuclease$210,217
R21 · FY2010 · AI · contact PI
Reprogramming of fibroblasts to pluripotency- a new tool to study Primary Immunod$85,750
R03 · FY2010 · AI · contact PI
Murine gene knock-in models fo Omenn Syndrome and leaky SCID$477,269
P01 · FY2009 · AI · contact PI